Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
53.2M
-
Shares change
-
+676K
-
Total reported value, excl. options
-
$945M
-
Value change
-
+$17.4M
-
Number of buys
-
41
-
Number of sells
-
-54
-
Price
-
$17.77
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2020
128 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q4 2020.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.2M shares
.
Largest 10 shareholders include FMR LLC (9.54M shares), BAUPOST GROUP LLC/MA (8.74M shares), ORBIMED ADVISORS LLC (6.22M shares), WELLINGTON MANAGEMENT GROUP LLP (5.47M shares), VANGUARD GROUP INC (4.65M shares), BlackRock Inc. (4.49M shares), Chescapmanager LLC (1.13M shares), STATE STREET CORP (1.05M shares), GREAT POINT PARTNERS LLC (825K shares), and GEODE CAPITAL MANAGEMENT, LLC (754K shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.